2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib
Open Access
- 24 September 2015
- journal article
- Published by Springer Nature in BMC Bioinformatics
- Vol. 16 (1) , 1
Abstract
Searching for two-dimensional (2D) structural similarities is a useful tool to identify new active compounds in drug-discovery programs. However, as 2D similarity measures neglect important structural and functional features, similarity by 2D might be underestimated. In the present study, we used combined 2D and three-dimensional (3D) similarity comparisons to reveal possible new functions and/or side-effects of known bioactive compounds.Keywords
This publication has 44 references indexed in Scilit:
- Shifting from the single to the multitarget paradigm in drug discoveryDrug Discovery Today, 2013
- Glycan Fingerprints: Calculating Diversity in Glycan LibrariesACS Chemical Biology, 2012
- SuperTarget goes quantitative: update on drug-target interactionsNucleic Acids Research, 2011
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- Network Neighbors of Drug Targets Contribute to Drug Side-Effect SimilarityPLOS ONE, 2011
- PROMISCUOUS: a database for network-based drug-repositioningNucleic Acids Research, 2010
- Histone γH2AX and Poly(ADP-Ribose) as Clinical Pharmacodynamic BiomarkersClinical Cancer Research, 2010
- PubChem: a public information system for analyzing bioactivities of small moleculesNucleic Acids Research, 2009
- Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant gliomaCancer, 2009
- SuperTarget and Matador: resources for exploring drug-target relationshipsNucleic Acids Research, 2007